These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 37040908)
1. Novel teprotumumab treatment of severe thyroid dermopathy; ototoxicity as an adverse side effect. Patel RT; Grider DJ; Ramey N Dermatol Online J; 2023 Feb; 29(1):. PubMed ID: 37040908 [TBL] [Abstract][Full Text] [Related]
2. Pretibial myxedema: pathophysiology and treatment options. Fatourechi V Am J Clin Dermatol; 2005; 6(5):295-309. PubMed ID: 16252929 [TBL] [Abstract][Full Text] [Related]
3. Orbital decompression in Graves' ophthalmopathy associated with pretibial myxedema. Fatourechi V; Garrity JA; Bartley GB; Bergstralh EJ; Gorman CA J Endocrinol Invest; 1993 Jun; 16(6):433-7. PubMed ID: 8370919 [TBL] [Abstract][Full Text] [Related]
4. Pretibial myxedema without ophthalmopathy: an initial presentation of Graves' disease. Lohiya S; Lohiya V; Stahl EJ Am J Med Sci; 2013 Jul; 346(1):73-5. PubMed ID: 23514670 [TBL] [Abstract][Full Text] [Related]
5. Teprotumumab for Treatment of Pretibial Myxedema. Reyes MP; Cabrera J; Singh J; Turnbull D JCEM Case Rep; 2023 Jan; 1(1):luac037. PubMed ID: 37908268 [TBL] [Abstract][Full Text] [Related]
6. Dermopathy of Graves disease (pretibial myxedema). Review of 150 cases. Fatourechi V; Pajouhi M; Fransway AF Medicine (Baltimore); 1994 Jan; 73(1):1-7. PubMed ID: 8309359 [TBL] [Abstract][Full Text] [Related]
7. Concurrent pretibial myxedema and thyroid eye disease following mRNA COVID-19 vaccine in a patient with history of Graves' disease. Caron P; Imbert P; Dekeister C; Grunenwald S Ann Endocrinol (Paris); 2024 Apr; 85(2):100-103. PubMed ID: 37866430 [TBL] [Abstract][Full Text] [Related]
8. Pretibial myxedema in a euthyroid patient: a case report. Ambachew R; Yosef T; Gebremariam AM; Demere L; Aberra T; Tarekegn G; Reja A Thyroid Res; 2021 Mar; 14(1):4. PubMed ID: 33648506 [TBL] [Abstract][Full Text] [Related]
10. Patient with monoclonal gammopathy, thyrotoxicosis, pretibial myxedema and thyroid-associated ophthalmopathy; demonstration of direct binding of autoantibodies to the thyrotropin receptor. Tonacchera M; Costagliola S; Cetani F; Ducobu J; Stordeur P; Vassart G; Ludgate M Eur J Endocrinol; 1996 Jan; 134(1):97-103. PubMed ID: 8590966 [TBL] [Abstract][Full Text] [Related]
11. [Clinical picture of pretibial myxedema and new aspects of diagnosis and pathogenesis]. Kind R; Hornstein OP Hautarzt; 1976 Aug; 27(8):375-81. PubMed ID: 955898 [TBL] [Abstract][Full Text] [Related]
12. Successful therapeutic approach in a patient with elephantiasic pretibial myxedema. Ferreira M; Zacaron LH; Valle AFD; Gamonal ACC An Bras Dermatol; 2020; 95(4):469-472. PubMed ID: 32461007 [TBL] [Abstract][Full Text] [Related]
15. Ototoxicity and Teprotumumab. Highland J; Gordon S; Reddy D; Patel N Ann Otol Rhinol Laryngol; 2022 Aug; 131(8):910-913. PubMed ID: 34448414 [TBL] [Abstract][Full Text] [Related]
16. Electrosurgical debulking of pretibial myxedema of the foot. Alia E; Feit EJ; Levitt JO Dermatol Online J; 2019 Feb; 25(2):. PubMed ID: 30865416 [TBL] [Abstract][Full Text] [Related]
17. Elephantiasic pretibial myxedema in a patient with graves disease that resolved after 131I treatment. Yu H; Jiang X; Pan M; Huang R Clin Nucl Med; 2014 Aug; 39(8):758-9. PubMed ID: 24830877 [TBL] [Abstract][Full Text] [Related]
18. Thyroid dermopathy and acropachy in pediatric patients. Kraus CN; Sodha P; Vaidyanathan P; Kirkorian AY Pediatr Dermatol; 2018 Nov; 35(6):e371-e374. PubMed ID: 30187962 [TBL] [Abstract][Full Text] [Related]
19. Graves' disease complicated by concurrent thyroid eye disease and pretibial myxedema successfully treated with teprotumumab. Bowens BK; Chou E; LaChance DP; Huynh JR; Voorhees P; Do TC; Shakir MKM; Hoang TD Clin Case Rep; 2022 Nov; 10(11):e6621. PubMed ID: 36415714 [TBL] [Abstract][Full Text] [Related]